• KOL
    • Multiple Endocrine
    • Stephen J Marx∘∘
    • Stephen J Marx∘∘: Influence Statistics

      Stephen J Marx∘∘

      Stephen J Marx∘∘

      Show email address

      Office of the Scientific Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Eunice Kennedy Shriver National Institute of Child ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Stephen J Marx∘∘:Expert Impact

      Concepts for whichStephen J Marx∘∘has direct influence:Multiple endocrine,Men1 gene,Primary hyperparathyroidism,Neoplasia type,Endocrine neoplasia,Parathyroid hormone,Multiple endocrine neoplasia,Parathyroid glands.

      Stephen J Marx∘∘:KOL impact

      Concepts related to the work of other authors for whichfor which Stephen J Marx∘∘ has influence:Multiple endocrine,Primary hyperparathyroidism,Parathyroid hormone,Neoplasia type,Men1 gene,Pituitary adenomas,Medullary thyroid carcinoma.

      KOL Resume for Stephen J Marx∘∘

      Year
      2019

      Office of the Scientific Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

      Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland

      2018

      Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Bethesda, Maryland, USA.

      Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States

      The National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland

      Metabolic Disease Branch, National Institutes of Digestive Disease and Kidney, National Institutes of Health, Bethesda, MD.

      Unidade de Endocrinologia Genetica UEG, Laboratorio de Endocrinologia Celular e Molecular LIM-25, Disciplina de Endocrinologia.

      2017

      Hospital das Clinicas, University of São Paulo School of Medicine Sao Paulo, Sao Paulo, Brazil.

      Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA.

      The National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892

      Metabolic Disease Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD

      National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland

      2016

      The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD 20892, USA

      2015

      Genetics and Endocrinology Section National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Bethesda Maryland 20892.

      Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA

      All authors: National Institutes of Health, Bethesda, MD.

      2014

      Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Building 10, Room 9C-103, 9000 Rockville, Bethesda, MD 20892, USA

      Genetics and Endocrinology Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

      National Cancer Institute, Bethesda, MD

      2013

      Genetics and Endocrinology Section, Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

      2012

      Metabolic Diseases Branch (L.S.W., W.F.S., S.J.M.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892

      2011

      Metabolic Diseases Branch and Genetics and Endocrinology Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

      Professor of Medicine, Harvard Medical School, Senior Physician and Chief, Thyroid Section, Division of Endocrinology, Diabetes, and Metabolism, Brigham and Women’s Hospital, Boston, Massachusetts

      2010

      From the *Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA; †Division of Hematology-Oncology, Louisiana State University Health Sciences Center, New Orleans, LA; ‡Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA; §Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; ∥Division of Nuclear Medicine, Department of Radiology, New York-Presbyterian Hospital, Weill Medical College of Cornell University; ¶Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY; #Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health, Bethesda, MD; **Department of Surgery, University of Calgary, Calgary Alberta, Canada; ††Division of Surgical Oncology, Department of General Surgery, Oregon Health & Science University, Portland, OR; ‡‡Department of Gastrointestinal Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX; and §§Digestive Diseases Branch, National Institutes of Health, Bethesda, MD.

      Authors' Affiliations: Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland; Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan; Cancer Genetics Branch, National Human Genome Research Institute, NIH, Bethesda; and Department of Surgery, Johns Hopkins University, Baltimore, Maryland

      2009

      Metabolic Diseases Branch, NIDDK, Bethesda, MD

      National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892

      2008

      Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892

      National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland, USA

      2007

      National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA

      2006

      National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

      2005

      Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 20892, Bethesda, Maryland

      2004

      National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA

      2003

      National Institute of Diabetes and Digestive and Kidney Diseases

      2002

      Surgery Branch, National Cancer Institute, Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, and Biostatistics and Data Management Section, National Institutes of Health, Bethesda, Md

      Metabolic Diseases Branch (S.J.M.), National Institute of Diabetes and Digestive and Kidney Diseases

      2001

      Metabolic Diseases Branch, NIDDK, NIH, U.S.A.

      National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892

      Bethesda, Md, New York, NY, San Francisco, Calif, and Philadelphia, Pa

      2000

      Metabolic Diseases Branch, National Institute for Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, Maryland

      1999

      Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

      National Institutes of Health, Bethesda Md Bethesda, Md

      1998

      Metabolic Diseases Branch, NIDDK,

      NIH/NIDDK/MDB, Bldg. 10, Room 9C‐ 101, 10 Center Dr., MSC 1802, Bethesda, MD 20892‐1802. Fax: (301) 496‐0200

      National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland 20892

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Stephen J Marx∘∘ is among the top experts in the world.
      Concept World rank
      multiple endocrine population #1
      hormoneresponse coupling #1
      24ohase induction #1
      express mutation #1
      sporadic tumors parathyroids #1
      atypical form phpt #1
      glands reoperation #1
      testosterone oversecretion #1
      prolactinomas carcinoids #1
      fihp mutation #1
      polyclonal hyperplasia #1
      time 125oh2d3 receptor #1
      germline men1 #1
      familial infant infusions #1
      fihp small kindreds #1
      typical men1 features #1
      calcemic response doses #1
      persistent primary #1
      hormoneexcess states #1
      neoplasia parathyroid #1
      patients hptjt #1
      uniodinated species #1
      hypercalcemia features #1
      gene multiple #1
      cases men1 #1
      calciferols vitamin #1
      125oh2d3 actions #1
      p002 hyperplasias #1
      cases hereditary resistance #1
      hypercalcemia heterozygotes #1
      patients historically expected #1
      hereditary resistance 125dihydroxyvitamin #1
      30 106 #1
      parathyroid enteropancreatic #1
      accumulation cytoplasm #1
      pair newfoundland #1
      fhh atypical form #1
      fhh distinct entity #1
      knockout parathyroid glands #1
      normocalcemia kindreds #1
      106 3h2425oh2d3 production #1
      hypercalcemia initial parathyroidectomy #1
      hyperparathyroidism familial #1
      men1 gene #1
      radioligand interaction #1
      calcium patients #1
      management multiplicity #1
      gland parathyroid #1
      accumulation vdrs #1
      missed adenoma #1
      Sign-in to see all concepts, it's free!

      Prominent publications by Stephen J Marx∘∘

      KOL-Index: 15944

      CONTEXT: Germline mutation in the MEN1 gene is the usual cause of multiple endocrine neoplasia type 1 (MEN1). However, the prevalence of identifiable germline MEN1 mutations in familial MEN1 cases is only 70%. Some cases may have a germline mutation in another gene such as the p27 cyclin-dependent kinase inhibitor (CDKI).

      OBJECTIVE: The aim of the study was to investigate cases of MEN1 or related states for germline mutations in all CDKI genes.

      METHODS: A total of 196 consecutive index ...

      Known for Germline Mutation | Kinase Inhibitor | Neoplasia Type | Cdki Genes | Cases Men1
      KOL-Index: 15315

      PURPOSE: Gastro-entero-pancreatic neuroendocrine tumors (GEPNETs) are increasing in incidence, and accurate staging is important for selecting the appropriate treatment. (68)Ga-DOTATATE imaging is a promising approach for detecting GEPNETs and could help in selecting optimal therapeutic strategies. The aim of this study was to prospectively determine the clinical utility of (68)Ga-DOTATATE positron emission tomography (PET)/computed tomography (CT) in detecting unknown primary and ...

      Known for Unknown Primary | Emission Tomography | Pancreatic Neuroendocrine | Dotatate Positron | Anatomic Imaging
      KOL-Index: 14147

      Pseudohypoparathyroidism type I is characterized by resistance (defined as a deficient urinary cAMP response) to parathyroid hormone and, in most cases, hypocalcemia and hyperphosphatemia. Many patients with pseudohypoparathyroidism type I snow a peculiar somatic phenotype termed Albright's hereditary osteodystrophy, but patients without this feature who show identical parathyroid hormone resistance have been described. Parathyroid hormone resistance in pseudohypoparathyroidism type I ...

      Known for Deficient Activity | Multiple Hormones | Regulatory Protein | Pseudohypoparathyroidism Type | Adenylate Cyclase
      KOL-Index: 13399

      Loss of heterozygosity (LOH) for polymorphic markers flanking the multiple endocrine neoplasia type 1 (MEN-1) gene in parathyroid and pancreatic islet tumors from subjects with familial MEN-1 (FMEN-1) has been well documented and has led to the hypothesis that the MEN-1 gene functions as a tumor suppressor. To assess the role of the MEN-1 gene in the pathogenesis of tumors less commonly associated with MEN-1, we employed a large number of highly informative polymorphic markers closely ...

      Known for Pituitary Tumors | Endocrine Neoplasia | Type 1 | Lung Carcinoids | Loss Heterozygosity
      KOL-Index: 12741

      Lung carcinoids occur sporadically and rarely in association with multiple endocrine neoplasia type 1 (MEN1). There are no well defined genetic abnormalities known to occur in these tumors. We studied 11 sporadic lung carcinoids for loss of heterozygosity (LOH) at the locus of the MEN1 gene on chromosome 11q13, and for mutations of the MEN1 gene using dideoxy fingerprinting. Additionally, a lung carcinoid from a MEN1 patient was studied. In four of 11 (36%) sporadic tumors, both copies ...

      Known for Men1 Gene | Carcinoid Tumors | Heterozygosity Lung | 1 Neoplasm | Mutation Loss
      KOL-Index: 12098

      BACKGROUND: Primary hyperparathyroidism (HPT) in multiple endocrine neoplasia type 1 (MEN1) patients with Zollinger-Ellison syndrome (ZES) is caused by parathyroid hyperplasia. Surgery for parathyroid hyperplasia is tricky and difficult. Long-term outcome in ZES/MEN1/HPT is not well known.

      METHODS: Eighty-four consecutive patients (49 F/35 M) with ZES/MEN1/HPT underwent initial parathyroidectomy (PTX) and were followed at 1- to 3-year intervals.

      RESULTS: Age at PTX was 36 +/- 2 years. ...

      Known for Primary Hyperparathyroidism | Endocrine Neoplasia | Type 1 | Ellison Syndrome | Parathyroid Hyperplasia
      KOL-Index: 12092

      OBJECTIVES: To evaluate patients with multiple endocrine neoplasia type 1 (MEN 1) for cutaneous manifestations.

      DESIGN: Survey during a 3-year period.

      SETTING: The National Institutes of Health, a tertiary referral research hospital in Bethesda Md.

      PATIENTS: A consecutive sample of 32 individuals with previously diagnosed MEN1 who were not preselected for the presence of skin lesions were examined for cutaneous abnormalities. None of the patients or family members were diagnosed as ...

      Known for Facial Angiofibromas | Patients Men1 | Tuberous Sclerosis | Type 1 | Endocrine Neoplasia
      KOL-Index: 11970

      Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant cancer syndrome, characterized primarily by multiple tumors in the parathyroid glands, endocrine pancreas, and anterior pituitary. Other tumors, including gastrinoma, carcinoid, adrenal cortical tumors, angiofibroma, collagenoma, and lipoma, also occur in some patients. Individuals with MEN1 almost always have loss-of-function mutations in the MEN1 gene on chromosome 11, and endocrine tumors arising in these patients ...

      Known for Mouse Model | Endocrine Tumors | Type 1 | Pancreatic Islets | Lethal Genes
      KOL-Index: 11861

      Primary hyperparathyroidism is a common disorder with an annual incidence of approximately 0.5 in 1,000 (ref. 1). In more than 95% of cases, the disease is caused by sporadic parathyroid adenoma or sporadic hyperplasia. Some cases are caused by inherited syndromes, such as multiple endocrine neoplasia type 1 (MEN1; ref. 2). In most cases, the molecular basis of parathyroid neoplasia is unknown. Parathyroid adenomas are usually monoclonal3,4, suggesting that one important step in tumour ...

      Known for Parathyroid Tumours | Men1 Gene | Somatic Mutation | Molecular Basis | Neoplasm Proteins
      KOL-Index: 11752

      Familial hypocalciuric hypercalcemia (FHH) is an autosomal dominant trait comprising hypercalcemia, hypophosphatemia, parathyroid hyperplasia, and unusually low renal clearance of calcium. We evaluated the role of parathyroid hormone in the relative hypocalciuria of FHH and characterized the renal transport of calcium in this disorder using three previously hypercalcemic FHH patients with surgical hypoparathyroidism and three controls with surgical hypoparathyroidism. Intravenous ...

      Known for Relative Hypocalciuria | Patients Fhh | Urinary Calcium | Hypocalciuric Hypercalcemia | Ascending Limb

      Key People For Multiple Endocrine

      Top KOLs in the world
      #1
      Stephen J Marx∘∘
      multiple endocrine men1 gene primary hyperparathyroidism
      #2
      Samuel A Wells
      multiple endocrine parathyroid glands carcinoembryonic antigen
      #3
      Rajesh V Thakker
      multiple endocrine neoplasia type mutational analysis
      #4
      Britt M Skogseid
      multiple endocrine men1 gene neoplasia type
      #5
      Maria Luisa Brandi
      multiple endocrine estrogen receptor postmenopausal women
      #6
      Bruce Anthony John Ponder
      breast cancer multiple endocrine neoplasia type

      Office of the Scientific Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Mar

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.